Viewing Study NCT00086957


Ignite Creation Date: 2025-12-24 @ 6:57 PM
Ignite Modification Date: 2025-12-31 @ 4:36 PM
Study NCT ID: NCT00086957
Status: COMPLETED
Last Update Posted: 2017-02-27
First Post: 2004-07-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV breast cancer View
None male breast cancer View
None recurrent breast cancer View